Science 37 (NASDAQ:SNCE) Trading Down 6.4%

Science 37 Holdings Inc (NASDAQ:SNCE) traded down 6.4% during mid-day trading on Thursday . The stock traded as low as $9.00 and last traded at $9.00. 2,281 shares were traded during mid-day trading, a decline of 99% from the average session volume of 267,457 shares. The stock had previously closed at $9.62.

Several research analysts have issued reports on the company. Lake Street Capital upped their price target on Science 37 from $15.00 to $20.00 and gave the company a “buy” rating in a report on Tuesday, November 16th. Robert W. Baird began coverage on shares of Science 37 in a report on Monday, November 1st. They set an “outperform” rating and a $15.00 price target on the stock. William Blair began coverage on shares of Science 37 in a report on Monday, November 1st. They set an “outperform” rating on the stock. Finally, Cowen began coverage on shares of Science 37 in a report on Friday, October 22nd. They set an “outperform” rating and a $14.00 price target on the stock.

The stock has a fifty day simple moving average of $11.54.

Science 37 (NASDAQ:SNCE) last issued its quarterly earnings data on Monday, November 15th. The company reported ($3.28) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($5.54) by $2.26. The business had revenue of $14.24 million during the quarter.

About Science 37 (NASDAQ:SNCE)

Science 37 Inc provides operating system for agile clinical trials. Science 37 Inc, formerly known as LifeSci Acquisition II Corp., is based in LOS ANGELES.

Recommended Story: Margin

Receive News & Ratings for Science 37 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Science 37 and related companies with MarketBeat.com's FREE daily email newsletter.